Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Mouse monoclonal antibody

Anti-NGAL (human)

CAT NO: ABS 038-04 | Application: ELISA, WB


Cat. No.

ABS 038-04

Specificity

ABS 038-04 binds human NGAL (neutrophil gelatinase-associated lipocalin).

Immunogen

Recombinant human NGAL

Host

Mouse

Positive Species Reactivity

Human

Negative Species Reactivity

Not determined

Isotype

IgG1/k

Gene ID

3934

Clone Number

4

Epitope Specificity

Differs from those of HYB 211-01, ABS 038-14, -15, -23 and the ABS 062 series of antibodies.

Unit Size

400 µL: Cat. No. ABS 038-04-04 1 mL: Cat. No. ABS 038-04-1 1 mg/mL +/- 15%. See Certificate of Analysis for details.

Purification

Protein A/G purified (from culture supernatant)

Form

Liquid

Solvent

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

Conjugation

Unconjugated BSA free

Storage

4-8ºC without exposure to light. No precautions necessary during handling.

Target

Neutrophil gelatinase-associated lipocalin (NGAL; also called lipocalin 2, siderocalin and neutrophil lipocalin) is a member of the lipocalin family of proteins which bind and transport small lipophilic molecules. NGAL is released by activated neutrophils and occurs as 25-kDa glycosylated single protein chain monomers, which form dimers and small amounts of higher oligomers, as well as complexes with matrix metalloproteinase 9 (MMP-9; gelatinase B). Low level expression of NGAL in a variety of epithelia may be increased in inflammation or cancers. Expression of NGAL in the kidney is dramatically increased by acute kidney injury.